Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology, Interventional | 7 | 2024 | 475 | 2.350 |
Why?
|
Radiography, Interventional | 8 | 2024 | 1114 | 1.220 |
Why?
|
Human Rights | 1 | 2021 | 306 | 0.600 |
Why?
|
Fees, Medical | 1 | 2016 | 112 | 0.510 |
Why?
|
Practice Management, Medical | 1 | 2016 | 191 | 0.470 |
Why?
|
Hospital Charges | 1 | 2016 | 359 | 0.460 |
Why?
|
Models, Economic | 1 | 2016 | 719 | 0.390 |
Why?
|
Internship and Residency | 2 | 2024 | 5870 | 0.350 |
Why?
|
Neoplasms | 5 | 2024 | 22072 | 0.320 |
Why?
|
Telemedicine | 2 | 2023 | 3018 | 0.320 |
Why?
|
Databases, Factual | 1 | 2024 | 8035 | 0.310 |
Why?
|
Income | 1 | 2016 | 1875 | 0.290 |
Why?
|
Yttrium Radioisotopes | 2 | 2019 | 107 | 0.280 |
Why?
|
Health Care Costs | 2 | 2020 | 3258 | 0.280 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3865 | 0.280 |
Why?
|
Relative Value Scales | 2 | 2024 | 86 | 0.270 |
Why?
|
Angiography | 1 | 2012 | 1605 | 0.270 |
Why?
|
Referral and Consultation | 2 | 2016 | 3598 | 0.260 |
Why?
|
Leadership | 1 | 2015 | 1371 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.260 |
Why?
|
Inpatients | 2 | 2021 | 2581 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.250 |
Why?
|
Orthopedics | 2 | 2024 | 892 | 0.240 |
Why?
|
Radiology | 2 | 2016 | 2102 | 0.240 |
Why?
|
Workload | 2 | 2024 | 847 | 0.240 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1131 | 0.230 |
Why?
|
Job Description | 1 | 2024 | 59 | 0.230 |
Why?
|
Pandemics | 7 | 2023 | 8624 | 0.230 |
Why?
|
Orthopedic Procedures | 2 | 2024 | 1263 | 0.230 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2363 | 0.210 |
Why?
|
Medicare Part B | 1 | 2024 | 117 | 0.210 |
Why?
|
Fee Schedules | 1 | 2020 | 85 | 0.180 |
Why?
|
Policy Making | 2 | 2021 | 538 | 0.180 |
Why?
|
Insurance Claim Review | 1 | 2024 | 738 | 0.170 |
Why?
|
Data Mining | 1 | 2024 | 553 | 0.160 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2634 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2019 | 1413 | 0.150 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2018 | 80 | 0.150 |
Why?
|
Liver Neoplasms | 3 | 2019 | 4319 | 0.140 |
Why?
|
Penile Neoplasms | 1 | 2018 | 162 | 0.140 |
Why?
|
Frostbite | 1 | 2016 | 24 | 0.140 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 936 | 0.130 |
Why?
|
Episode of Care | 1 | 2016 | 127 | 0.130 |
Why?
|
Patient Preference | 1 | 2023 | 922 | 0.130 |
Why?
|
Humans | 34 | 2024 | 760621 | 0.130 |
Why?
|
Toes | 1 | 2016 | 209 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1677 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2019 | 2299 | 0.110 |
Why?
|
Specialization | 1 | 2018 | 778 | 0.110 |
Why?
|
Fingers | 1 | 2016 | 506 | 0.110 |
Why?
|
Career Mobility | 1 | 2015 | 258 | 0.110 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 345 | 0.100 |
Why?
|
Models, Organizational | 1 | 2016 | 545 | 0.100 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2013 | 127 | 0.100 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 405 | 0.100 |
Why?
|
Medicare | 3 | 2020 | 6786 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5325 | 0.100 |
Why?
|
Reimbursement, Incentive | 1 | 2016 | 542 | 0.100 |
Why?
|
Societies, Medical | 2 | 2021 | 3905 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2041 | 0.090 |
Why?
|
Fee-for-Service Plans | 1 | 2016 | 705 | 0.090 |
Why?
|
Salvage Therapy | 1 | 2017 | 1268 | 0.090 |
Why?
|
Consensus | 4 | 2023 | 3113 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2016 | 1190 | 0.090 |
Why?
|
Male | 11 | 2024 | 359744 | 0.090 |
Why?
|
Female | 11 | 2024 | 391270 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2024 | 80372 | 0.080 |
Why?
|
Arteries | 1 | 2014 | 1126 | 0.080 |
Why?
|
Adult | 11 | 2024 | 219994 | 0.080 |
Why?
|
Drug Carriers | 1 | 2013 | 709 | 0.080 |
Why?
|
United States | 6 | 2024 | 72461 | 0.080 |
Why?
|
Abdomen | 1 | 2014 | 1130 | 0.070 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7818 | 0.070 |
Why?
|
Thrombolytic Therapy | 1 | 2016 | 2108 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2932 | 0.070 |
Why?
|
Doxorubicin | 1 | 2013 | 2209 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3696 | 0.070 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1725 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2167 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58995 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2014 | 1182 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2511 | 0.060 |
Why?
|
Program Evaluation | 1 | 2013 | 2493 | 0.060 |
Why?
|
Middle Aged | 7 | 2024 | 220352 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5799 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65017 | 0.060 |
Why?
|
Health Expenditures | 1 | 2016 | 2362 | 0.060 |
Why?
|
Time Factors | 5 | 2019 | 40165 | 0.060 |
Why?
|
Health Care Reform | 1 | 2013 | 1245 | 0.060 |
Why?
|
Leisure Activities | 1 | 2023 | 306 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7475 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 3836 | 0.040 |
Why?
|
California | 1 | 2024 | 1416 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13262 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3527 | 0.040 |
Why?
|
Aged | 5 | 2024 | 169152 | 0.040 |
Why?
|
Advisory Committees | 1 | 2022 | 788 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6853 | 0.040 |
Why?
|
Familial Mediterranean Fever | 1 | 1997 | 65 | 0.040 |
Why?
|
Exercise | 2 | 2023 | 5787 | 0.040 |
Why?
|
Quality of Life | 1 | 2018 | 13308 | 0.030 |
Why?
|
Rewarming | 1 | 2016 | 64 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 1 | 2016 | 221 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 465 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 787 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2016 | 334 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21025 | 0.030 |
Why?
|
Limb Salvage | 1 | 2016 | 465 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1607 | 0.030 |
Why?
|
National Health Insurance, United States | 1 | 2013 | 100 | 0.030 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 5508 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4810 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4625 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20509 | 0.020 |
Why?
|
Child | 3 | 2023 | 79806 | 0.020 |
Why?
|
Aneurysm, Ruptured | 1 | 2014 | 460 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8469 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3928 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1063 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2024 | 4775 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4283 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3618 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8555 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6238 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39261 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8552 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 74359 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12808 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6828 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6465 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10182 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12159 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7806 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54303 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12965 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11152 | 0.010 |
Why?
|
Libya | 1 | 1997 | 9 | 0.010 |
Why?
|
Armenia | 1 | 1997 | 15 | 0.010 |
Why?
|
Tunisia | 1 | 1997 | 36 | 0.010 |
Why?
|
Palliative Care | 1 | 2013 | 3607 | 0.010 |
Why?
|
Egypt | 1 | 1997 | 98 | 0.010 |
Why?
|
Iraq | 1 | 1997 | 94 | 0.010 |
Why?
|
Saudi Arabia | 1 | 1997 | 209 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15289 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1997 | 342 | 0.010 |
Why?
|
Jews | 1 | 1997 | 364 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1997 | 1526 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1997 | 1996 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24123 | 0.010 |
Why?
|
Haplotypes | 1 | 1997 | 2764 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41335 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58741 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 87810 | 0.000 |
Why?
|
Alleles | 1 | 1997 | 6898 | 0.000 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_